OA15.04 Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC
| Autor: | Peters, S., Cho, B.C., Luft, A., Alatorre-Alexander, J., Geater, S.L., Kim, S.-W., Ursol, G., Hussein, M., Lim, F.L., Yang, C.-T., Araujo, L.H., Saito, H., Reinmuth, N., Stewart, R., Lai, Z., Doake, R., Krug, L., Garon, E.B., Mok, T., Johnson, M.L. |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; September 2022, Vol. 17 Issue: 9, Number 9 Supplement 1 pS39-S41, 3p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|